tiprankstipranks
Glaukos (GKOS)
NYSE:GKOS
US Market
Want to see GKOS full AI Analyst Report?

Glaukos (GKOS) Blogger Opinions & Sentiment

425 Followers

Blogger Sentiment

Bearish: 66.67%
Sector Average
Neutral
GKOS Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
33% Investing
16% SeekingAlpha
16% MotleyFool
35% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Q2 2026 Glaukos Corp Earnings Call Transcript
GuruFocus
Glaukos chief development officer Navratil sells $99,566 stock
Investing
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now?
MotleyFool
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of GKOS?
Seeking Alpha’s Gamu Dave Innocent Pasi has a Neutral Sentiment.
    What do Motley Fool contributors think of GKOS?
    Currently there's no blogger sentiment for GKOS.
    What Is GKOS’s Blogger Sentiment?
    GKOS’s Blogger Sentiment is Neutral.
      What was the most recent blogger prediction for GKOS?
      The most recent blogger prediction for GKOS was made by Zacks Equity Research, who was Neutral on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          VERAVera Therapeutics
          NUVBNuvation Bio
          DFTXDefinium Therapeutics
          SENSSenseonics Holdings